Physician profile
Theodore Pham
NPI 1285165407
$367.38
in general payments reported to CMS, 2019-2025
14 companies · $184 in 2025
The $184 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.10 · 2023: $27.14 · 2024: $140 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $351.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $91.80 | 2023-2025 | |
| Tris Pharma INC | $61.56 | 2024-2025 | Dyanavel Xr |
| Supernus Pharmaceuticals, INC. | $26.15 | 2025 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $22.65 | 2024 | Eohilia |
| Seqirus USA INC | $22.57 | 2025 | Flucelvax |
| Merck Sharp & Dohme LLC | $19.22 | 2025 | Vaxneuvance, Gardasil 9, Enflonsia |
| Sanofi-Aventis U.S. LLC | $16.70 | 2025 | |
| Ars Pharmaceuticals Operations, INC. | $16.47 | 2025 | Neffy |
| Allergan, INC. | $16.10 | 2019 | |
| Collegium Pharmaceutical, INC. | $16.05 | 2025 | Jornay Pm |
| Lnhc, INC | $14.67 | 2025 | Zelsuvmi |
| Kowa Pharmaceuticals America, INC. | $14.59 | 2025 | Zoryve |
| Kyowa Kirin, INC. | $14.48 | 2024 | Crysvita |
| Sanofi Pasteur INC. | $14.37 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Theodore Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.